Related Experiment Video
Updated: Aug 22, 2025
09:51
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
34.2K
CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
Renata Sanches Almeida1, Fernanda Wisnieski1,2, Bruno Takao Real Karia1
1Discipline of Genetics, Department of Morphology and Genetics, Federal University of São Paulo, Rua Botucatu, 740, São Paulo 04023900, Brazil.
Genes
|November 11, 2022
Summary
CRISPR/Cas9 gene editing advances gastric cancer research by exploring gene functions and potential treatments. This technology enhances understanding of cancer genomics for improved clinical applications.
Area of Science:
- Oncology
- Genetics
- Biotechnology
Background:
- Gastric cancer presents high global incidence and mortality rates.
- Late-stage diagnosis and traditional treatments like gastrectomy and chemotherapy are aggressive and reduce patient quality of life.
- Understanding gastric cancer genomics is crucial for developing effective therapies.
Purpose of the Study:
- To review the current applications of CRISPR/Cas9 gene-editing technology in gastric cancer research.
- To explore the role of CRISPR/Cas9 in understanding gastric cancer genomics.
- To assess the potential of CRISPR/Cas9 in the clinical treatment of gastric cancer.
Main Methods:
- Literature review of studies utilizing CRISPR/Cas9 in gastric cancer.
- Analysis of research exploring gene functions related to gastric cancer using CRISPR/Cas9.
- Evaluation of studies investigating CRISPR/Cas9 as a therapeutic strategy for gastric cancer.
Main Results:
- CRISPR/Cas9 facilitates the functional study of genes implicated in gastric cancer.
- The technology aids in dissecting the complexities of gastric cancer genomics.
- Emerging research indicates CRISPR/Cas9's potential for novel therapeutic interventions.
Conclusions:
- CRISPR/Cas9 is a powerful tool revolutionizing gastric cancer research.
- The technology offers new avenues for understanding gastric cancer pathogenesis and developing targeted treatments.
- Further research is needed to translate CRISPR/Cas9 applications into widespread clinical practice for gastric cancer.
Related Concept Videos
01:28CRISPR/Cas9 Genome Editing
142
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
142
01:59CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
02:53CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
02:31Homologous Recombination
50.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K
00:49What is Genetic Engineering?
74.6K
Overview
74.6K